Commenting on price rises for Mounjaro, Henry Gregg, Chief Executive of the National Pharmacy Association, said: “Patients on courses of treatment or considering weight loss programmes will be very concerned about sudden price rises for Mounjaro so we are urgently supporting our members to limit the impact on patients and ensure they can continue their courses of treatment and the wrap around care that pharmacies provide which is so important as part of weight loss programmes.
“Short notice changes to pricing for medicines such as this also have a serious effect on access to an important public health service and pharmacy business themselves so we are urging the manufacturers to ensure that pharmacies are treated equitably and that proper support is in place to ensure pharmacies can continue to offer what is a highly popular and effective service to their communities.”
